Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line

A resource for cell line authentication, annotation and quality control

(2015) Mamie Yu et al.   NATURE

Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens

(2014) Torsten Nielsen et al.   BMC CANCER

Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

(2013) Michael S. Anglesio et al.   PLoS One

Evaluating cell lines as tumour models by comparison of genomic profiles

(2013) Silvia Domcke et al.   Nature Communications

CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set

(2012) W. C. Reinhold et al.   CANCER RESEARCH

Unraveling the two entities of endometrioid ovarian cancer: A single center clinical experience

(2012) Giorgia Mangili et al.   GYNECOLOGIC ONCOLOGY

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

(2012) Christopher Korch et al.   GYNECOLOGIC ONCOLOGY

Clinical Validity/Utility, Change in Practice Patterns, and Economic Implications of Risk Stratifiers to Predict Outcomes for Early-Stage Breast Cancer: A Systematic Review

(2012) J. Hornberger et al.   JNCI-Journal of the National Cancer Institute

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

(2012) Jordi Barretina et al.   NATURE

Reuse of public genome-wide gene expression data

(2012) Johan Rung et al.   NATURE REVIEWS GENETICS

Comprehensive literature review and statistical considerations for microarray meta-analysis

(2012) George C. Tseng et al.   NUCLEIC ACIDS RESEARCH

Clinical Verification of the Performance of the Pathwork Tissue of Origin Test

(2011) Catherine I. Dumur et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

A Framework to Select Clinically Relevant Cancer Cell Lines for Investigation by Establishing Their Molecular Similarity with Primary Human Cancers

(2011) G. M. Dancik et al.   CANCER RESEARCH

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Bring on the biomarkers

(2011) George Poste   NATURE

Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome

(2011) David Venet et al.   PLoS Computational Biology

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

(2010) Robert J. Kurman et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome-wide Expression Data: A Validation Study

(2010) M. Lauss et al.   CLINICAL CANCER RESEARCH

Colorectal Cancer Cell Lines Lack the Molecular Heterogeneity of Clinical Colorectal Tumors

(2010) James Todd Auman et al.   Clinical Colorectal Cancer

Consistency of predictive signature genes and classifiers generated using different microarray platforms

(2010) X Fan et al.   PHARMACOGENOMICS JOURNAL

Gene Expression Profiles as Predictors of Poor Outcomes in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis

(2009) An-Ting T. Lu et al.   Clinical Colorectal Cancer

DNA fingerprinting of the NCI-60 cell line panel

(2009) P. L. Lorenzi et al.   MOLECULAR CANCER THERAPEUTICS